Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

950 Tower Lane

Phone

+1 650 667-4085

Employees

264

Web

https://www.mirumpharma.com

Details

Group

Domestic Stock Funds

Fundamentals

MIRM

Capitalization

1.99B

P/E Ratio

N/A

Risk (Beta)

0.29

Dividend Yield

N/A

Total Cash

278M

Total Cash/Share

5.83

Total Debt

317M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

5.81%

Revenue

264M

ROE

N/A

Book Value

229M

P/B Ratio

8.68

Cash Flow

N/A

Earnings

-2.31

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

3.28

Current Revenue Per Employee

264880.94

Dividends Per Share - Security

N/A

EBITDA

-73.47M

Float

N/A

Float - Current

N/A

Gross Income Margin

74.03

Revenue To Assets

-19.77

Shares Held By Institutions

3.06B

Shares Outstanding - Current

47.7M

Total Liabilities

432M

Total Volume MTD

N/A

Value

N/A

Gain YTD

41.091

View a ticker or compare two or three

Compare

MIRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MIRM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MIRM (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology